Showing 1381-1390 of 2046 results for "".
- First Patient Treated in Multicenter Trial Examining Allotex TransForm Allogenic Refractive Lenticules for Treatment of Presbyopiahttps://modernod.com/news/first-patient-treated-in-multicenter-trial-examining-allotex-transform-allogenic-refractive-lenticules-for-treatment-of-presbyopia/2479889/Start-up ophthalmic device company Allotex announced the commencement of a European multicenter trial for its investigational TransForm allogenic refractive lenticules for the treatment of presbyopia. The treatment was performed on Thursday by Arthur Cummings, MB ChB, FCS(SA), MMed(Ophth)
- The Vision Council Opens Registration for 2026 Executive Summithttps://modernod.com/news/the-vision-council-opens-registration-for-2026-executive-summit/2484153/The Vision Council announced that registration is open for the 2026 Executive Summit. The 3-day forum will be held January 26-28, 2026, at The Ritz-Carlton, Amelia Island, Florida.
- CMS Eases Requirements for COVID-19 Tests, Boosts Payments for Telephonic Visitshttps://modernod.com/news/cms-eases-requirements-for-covid-19-tests-boosts-payments-for-telephonic-visits/2477699/The Trump administration is easing requirements on testing for COVID-19 to make it easier to administer drive-thru and “parking lot” testing facilities, according to a FierceHealthcare
- CORE Highlights Emerging Focus on Pre-Myopia in Latest Contact Lens Updatehttps://modernod.com/news/core-highlights-emerging-focus-on-pre-myopia-in-latest-contact-lens-update/2484173/The Centre for Ocular Research & Education (CORE) has released the newest edition of Contact Lens Update, spotlighting the growing clinical and scientific interest in pre-myopia. This evolving area of study is reshaping how clinicians assess risk, intervene ear
- AAO: Latest Research From the World’s Largest Eye Disease Data Registryhttps://modernod.com/news/aao-latest-research-from-the-worlds-largest-eye-disease-data-registry/2481141/The IRIS Registry (Intelligent Research in Sight) powered several big data studies this year, most of which will be presented and discussed at AAO 2022, the 126th annual meeting of the American Academy of Ophthalmology. &n
- NIH Becomes Latest to Halt COVID-19 Trial of Hydroxychloroquinehttps://modernod.com/news/nih-becomes-latest-to-halt-covid-19-trial-of-hydroxychloroquine/2477917/Another clinical trial testing hydroxychloroquine in hospitalized patients with COVID-19 has been stopped, this one by the US National Institutes of Health (NIH). The agency said that the ORCHID study’s data and safety monitoring board found, after having conducted its fourth interim analys
- Coronavirus Testing Machines Are Latest Bottleneck In Troubled Supply Chainhttps://modernod.com/news/coronavirus-testing-machines-are-latest-bottleneck-in-troubled-supply-chain/2477835/Coronavirus testing in the U.S. has run into a number of snags, from a lack of nasal swabs to not enough chemicals needed to run the tests. Now there’s a new bottleneck emerging: A shortage of the machines that process the tests and give results, according to an NPR
- CooperVision Showcases Latest Research in Series of Poster Sessions at Optometry’s Meeting 2019https://modernod.com/news/coopervision-showcases-latest-research-in-series-of-poster-sessions-at-optometrys-meeting-2019/2476676/As part of its commitment to the continuous advancement of contact lens study and support, CooperVision will share the results of new research in a series of four poster sessions at Optometry’s Meeting 2019 in St. Louis. The posters examine the performance of CooperVision clariti 1 day multifocal
- Alcon to Showcase Latest Innovations at American Academy of Ophthalmology 2018 Annual Meetinghttps://modernod.com/news/alcon-to-showcase-latest-innovations-at-american-academy-of-ophthalmology-2018-annual-meeting/2479748/Alcon will showcase several advancements in ophthalmology through a robust booth presence, a series of live demonstrations, and interactive symposia during the American Academy of Ophthalmology (AAO) 2018 annual meeting, taking place October 27-30 in Chicago, IL. “We are very excited to e
- Abstract on ZETA-1 Study of APX3330 Receives Award at Women in Ophthalmology (WIO) Summer Symposiumhttps://modernod.com/news/abstract-on-zeta-1-study-of-apx3330-receives-award-at-women-in-ophthalmology-wio-summer-symposium/2481795/Ocuphire Pharma announced that data from its phase 2 clinical trial of APX3330 in diabetic retinopathy (DR) were featured in an oral presentation on Saturday, August 26 at the